(DLAB) Dlaboratory Sweden - Ratings and Ratios
Inspection, Services, Data, Analysis, Alerts, KPIs
DLAB EPS (Earnings per Share)
DLAB Revenue
Description: DLAB Dlaboratory Sweden
Dlaboratory Sweden AB (ST:DLAB) is a Swedish energy technology company that specializes in providing inspection services and solutions for infrastructure owners and operators in the power, telecom, and rail sectors. By leveraging its proprietary dLab platform, the company automates data collection and analysis, providing timely alerts, in-depth analysis, and key performance indicators (KPIs) to its clients. Founded in 2007 and headquartered in Lund, Sweden, Dlaboratory Sweden AB has established itself as a key player in the renewable electricity sub-industry.
From a market perspective, Dlaboratory Sweden ABs common stock (Ticker Symbol: DLAB) is listed on the Swedish stock exchange. The companys market capitalization stands at 46.77M SEK, indicating a relatively small-cap stock with potential for growth. The absence of a price-to-earnings (P/E) ratio, both current and forward, suggests that the company is currently operating at a loss, which is further reinforced by the negative return on equity (RoE) of -52.95%. This indicates that the company is in a growth phase, investing heavily in its business.
Analyzing the technical data, Dlaboratory Sweden ABs stock price is currently at 2.44 SEK, with a 20-day simple moving average (SMA20) of 2.60 and a 50-day simple moving average (SMA50) of 2.65, indicating a short-term downtrend. However, the 200-day simple moving average (SMA200) stands at 2.36, suggesting that the long-term trend remains positive. The average true range (ATR) is 0.16, representing a volatility of 6.53%. The stock is currently trading below its 52-week high of 2.90 but above its 52-week low of 1.92.
Combining the technical and fundamental data, a forecast for Dlaboratory Sweden AB can be derived. Given the companys strong positioning in the renewable electricity sub-industry and its automated inspection services, it is poised for growth. The negative RoE and absence of a P/E ratio indicate that the company is investing heavily in its growth phase. As the company continues to expand its services and improve its profitability, a potential increase in stock price can be expected. Based on the current technical trends, a potential target price could be around 3.00-3.20 SEK, representing a 23-31% increase from the current price, assuming the company continues to progress in its growth phase and the overall market sentiment remains positive.
DLAB Stock Overview
| Market Cap in USD | 4m |
| Sub-Industry | Renewable Electricity |
| IPO / Inception |
DLAB Stock Ratings
| Growth Rating | -19.8% |
| Fundamental | 33.6% |
| Dividend Rating | - |
| Return 12m vs S&P 500 | -4.92% |
| Analyst Rating | - |
DLAB Dividends
Currently no dividends paidDLAB Growth Ratios
| Growth Correlation 3m | -77% |
| Growth Correlation 12m | 50.8% |
| Growth Correlation 5y | -77.6% |
| CAGR 5y | -17.23% |
| CAGR/Max DD 5y | -0.21 |
| Sharpe Ratio 12m | -0.06 |
| Alpha | 18.60 |
| Beta | -0.483 |
| Volatility | 65.70% |
| Current Volume | 2.5k |
| Average Volume 20d | 5k |
| Stop Loss | 2.1 (-7.9%) |
| Signal | 0.18 |
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-7.26m TTM) > 0 and > 6% of Revenue (6% = 2.81m TTM) |
| FCFTA -0.15 (>2.0%) and ΔFCFTA -1.11pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 3.27% (prev 16.69%; Δ -13.42pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA -0.29 (>3.0%) and CFO -5.89m > Net Income -7.26m (YES >=105%, WARN >=100%) |
| NO Net Debt/EBITDA fails (EBITDA <= 0) |
| Current Ratio 1.11 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (18.0m) change vs 12m ago 6.13% (target <= -2.0% for YES) |
| Gross Margin 52.70% (prev 41.33%; Δ 11.38pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 193.5% (prev 164.6%; Δ 28.93pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio -33.57 (EBITDA TTM -4.49m / Interest Expense TTM 213.0k) >= 6 (WARN >= 3) |
Altman Z'' -7.19
| (A) 0.08 = (Total Current Assets 15.5m - Total Current Liabilities 14.0m) / Total Assets 20.4m |
| (B) -1.77 = Retained Earnings (Balance) -36.1m / Total Assets 20.4m |
| warn (B) unusual magnitude: -1.77 — check mapping/units |
| (C) -0.30 = EBIT TTM -7.15m / Avg Total Assets 24.2m |
| (D) 0.06 = Book Value of Equity 847.0k / Total Liabilities 14.4m |
| Total Rating: -7.19 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 33.58
| 1. Piotroski 3.0pt = -2.0 |
| 2. FCF Yield -9.09% = -4.54 |
| 3. FCF Margin -6.58% = -2.47 |
| 4. Debt/Equity data missing |
| 5. Debt/Ebitda data missing |
| 6. ROIC - WACC data missing |
| 7. RoE -73.46% = -2.50 |
| 8. Rev. Trend -11.82% = -0.59 |
| 9. Rev. CAGR -16.14% = -2.50 |
| 10. EPS Trend -3.00% = -0.08 |
| 11. EPS CAGR -13.92% = -1.74 |
What is the price of DLAB shares?
Over the past week, the price has changed by -1.72%, over one month by -5.00%, over three months by -11.63% and over the past year by +11.22%.
Is Dlaboratory Sweden a good stock to buy?
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of DLAB is around 1.95 SEK . This means that DLAB is currently overvalued and has a potential downside of -14.47%.
Is DLAB a buy, sell or hold?
What are the forecasts/targets for the DLAB price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 2.1 | -8.3% |
DLAB Fundamental Data Overview
Market Cap SEK = 40.3m (40.3m SEK * 1.0 SEK.SEK)
CCE Cash And Equivalents = 6.41m SEK (Cash And Short Term Investments, last quarter)
P/S = 0.845
P/B = 7.0817
Beta = 1.61
Revenue TTM = 46.9m SEK
EBIT TTM = -7.15m SEK
EBITDA TTM = -4.49m SEK
Long Term Debt = unknown (0.0)
Short Term Debt = unknown (0.0)
Debt = unknown
Net Debt = -6.41m SEK (from netDebt column, last quarter)
Enterprise Value = 33.9m SEK (40.3m + (null Debt) - CCE 6.41m)
Interest Coverage Ratio = -33.57 (Ebit TTM -7.15m / Interest Expense TTM 213.0k)
FCF Yield = -9.09% (FCF TTM -3.08m / Enterprise Value 33.9m)
FCF Margin = -6.58% (FCF TTM -3.08m / Revenue TTM 46.9m)
Net Margin = -15.48% (Net Income TTM -7.26m / Revenue TTM 46.9m)
Gross Margin = 52.70% ((Revenue TTM 46.9m - Cost of Revenue TTM 22.2m) / Revenue TTM)
Tobins Q-Ratio = 40.04 (Enterprise Value 33.9m / Book Value Of Equity 847.0k)
Interest Expense / Debt = unknown (Interest Expense 75.0k / Debt none)
Taxrate = unknown
NOPAT = unknown (EBIT/Op.Income or Taxrate missing)
Current Ratio = 1.11 (Total Current Assets 15.5m / Total Current Liabilities 14.0m)
Debt / Equity = unknown Debt (none)
Debt / EBITDA = unknown (Net Debt -6.41m / EBITDA -4.49m)
Debt / FCF = none (Debt none / FCF TTM -3.08m)
Total Stockholder Equity = 9.88m (last 4 quarters mean)
RoA = -35.59% (Net Income -7.26m, Total Assets 20.4m )
RoE = -73.46% (Net Income TTM -7.26m / Total Stockholder Equity 9.88m)
RoCE = -72.38% (Ebit -7.15m / (Equity 9.88m + L.T.Debt 0.0))
RoIC = unknown (NOPAT none, Invested Capital 9.95m, Ebit -7.15m)
WACC = unknown (E(40.3m)/V(0.0) * Re(4.24%)) + (D(none)/V(0.0) * Rd(none%) * (1-Tc(none)))
Shares Correlation 5-Years: 63.20 | Cagr: 1.45%
Discount Rate = 4.24% (= CAPM, Blume Beta Adj.) -> floored to rf + ERP 8.05%
Fair Price DCF = unknown (Cash Flow -3.08m)
Revenue Correlation: -11.82 | Revenue CAGR: -16.14%
Rev Growth-of-Growth: -5.00
EPS Correlation: -3.00 | EPS CAGR: -13.92%
EPS Growth-of-Growth: 74.16